Skip to main content
. 2011 Dec;17(12):2277–2286. doi: 10.3201/eid1712.110783

Table 2. Amino acid sequences of the 34 SIV/HIV peptides used to develop the xMAP gp41 and V3-loop multiplex Luminex assay.

Peptide SIV lineage gp41 peptide sequences V3-loop peptide sequences
HIV-1 M HIV1/SIVcpz/gor LAVERYLKDQQLLGIWGCSGKLIC NNTRKSVRIGPGQAFYATGDIIGDIRQAYC
HIV-1 O HIV1/SIVcpz/gor LALGTLIQNQQLLNLWGCKGKLIC NLTVQEIKIGPMAWYSMGLAAGNGSRAYC
HIV-1 N HIV1/SIVcpz/gor LAIGRYLRDQQILSLWGCSGKTIC NNTGGQVGIGPAMTFYNIGKIVGDIRKAYC
SIVcpzPts HIV1/SIVcpz/gor LAVEKYLRDQQLLSLWGCADKVTC NRTVRNLQIGPGMTFYNVEIATGDTRKAFC
SIVcpzPtt HIV1/SIVcpz/gor LAVERYLQDQQILGLWGCSGKAVC NNTRGEVQIGPGMTFYNIENVVGDTRSAYC
SIVgor HIV1/SIVcpz/gor LAIETYLRDQQLLGLWGCTGKLIC NNTRGQIQIGPMTIYNSERIIGNTRKAYC
HIV-2/SIVsmm HIV-2/SIVsmm TAIEKYLKDQAQLNSWGCAFRQVC GNKTVVPITLMSGLVFMSQPINKRPRQAWC
SIVrcm SIVrcm TAIEKYLADQSLLNTFGCAWRQVC SNRTVKGISLAIGVFISLRVEKRPKGAWC
SIVagm SIVagm TALEKYLEDQARLNAWGCAWKQVC GNKTVLPVTIMAGLVFHSQKYNTLLRQAWC
SIVgsn SIVgsn/mus/mon† SSLEKYLRDQTILQAWGCANRPIC GNKTIRNLQIGAGMTFYSQVIVGGNTRKAYC
SIVmus SIVgsn/mus/mon† TALEKFVKDQAILNLWGCANRQIC
SIVmon SIVgsn/mus/mon† TAVEKFIKDQTLLNAWGCANKAVC
SIVdeb SIVdeb TAIEKYLKDQAKLNEWGCAFKQIC GNKTYRAVHMATGLSFYTTFIPRLRIKRAHC
SIVtal SIVtal‡ TALEKYLEDQAKLNSWGCAWKQIC RTIKDLQIAAGLMFHSQIIAGKDLKRAY
SIVsyk SIVsyk TALETYLRDQAIMSNWGCAFKQIC GNESIKNIQLAAGYFLPVIQGKLKTGRDAKRAFC
SIVlho SIVlho/sun TAIEEYLKDQALLASWGCQWKQVC GNRSEVSTISSTGLLFYYGLEHGSRLRLAQC
SIVmnd-2 SIVmnd TALEDYVADQSRLAVWGCSFSQVC GNRSVVSTPSATGLLFYHLGPGKNLKKGMC
SIVwrc SIVwrc SAIEGFLEDQLKLKQWGCELTQVC GNRSVVSVNSASGLIYYAGLEPHRNIRKGLC
SIVcol SIVcol‡ ATIEGYLEEQAKLASIGCANMQIC GNSSHRNLNTANGAKFYYELIPYSKGIYGRC

*SIV, simian immunodeficiency virus.
†V3 amino acid sequences of SIVgsn, SIVmus, and SIVmon were identical, and only the SIVgsn above the V3-loop peptide was synthesized.
‡Synthesis of SIVcol gp41 and SIVtal V3-loop peptides was unsuccessful.